10-Q: N2OFF Inc. Reports Third Quarter 2024 Results Amidst Strategic Shifts and Ongoing Challenges

N2OFF Inc. reports a net loss for the third quarter of 2024, impacted by decreased revenues and increased operating expenses, while navigating ongoing geopolitical and financial challenges.

Summary

• N2OFF Inc. reported a net loss of $3.94 million for the nine months ended September 30, 2024, compared to a net loss of $5.47 million for the same period in 2023.
• The company's revenue decreased to $69,481 for the nine months ended September 30, 2024, from $157,618 in the same period of 2023, primarily due to decreased sales in Mexico.
• Operating expenses decreased across research and development, selling and marketing, and general and administrative categories, with a significant reduction in R&D spending.
• The company has been impacted by the ongoing conflict in Israel, which has caused delays in pilot programs and packaging activities.
• N2OFF has made strategic investments in the solar energy sector and has entered into a loan agreement with Solterra Renewable Energy Ltd.
• The company has also entered into a non-binding letter of intent to acquire MitoCareX Bio Ltd.
• N2OFF is facing challenges related to its listing on the Nasdaq Capital Market due to its stock price falling below the minimum bid price requirement.
• The company has raised capital through a standby equity purchase agreement and a promissory note.

Sentiment

Score: 3

Explanation: The document presents a concerning financial picture with significant losses, declining revenues, and a going concern uncertainty. While there are some positive developments, such as strategic investments and cost reductions, the overall sentiment is negative due to the company's financial struggles and operational challenges.

Positives

• Operating expenses decreased across research and development, selling and marketing, and general and administrative categories.
• The company has made strategic investments in the solar energy sector.
• N2OFF has entered into a non-binding letter of intent to acquire MitoCareX Bio Ltd.
• The company has raised capital through a standby equity purchase agreement and a promissory note.

Negatives

• The company experienced a significant net loss of $3.94 million for the nine months ended September 30, 2024.
• Revenues decreased by 56% compared to the same period in 2023.
• The company's stock price fell below the minimum bid price requirement for continued listing on the Nasdaq Capital Market.
• The ongoing conflict in Israel has caused delays in pilot programs and packaging activities.

Risks

• The company's ability to continue as a going concern is in doubt due to significant losses and negative cash flows.
• The ongoing conflict in Israel may adversely affect the company's operations and ability to market its products.
• The company is dependent on external sources to finance its operations and may not be able to secure sufficient financing.
• The company faces significant competition in the development of environmentally friendly solutions for the treatment of fruits and vegetables.
• The company relies on a limited number of suppliers for key components of its products.
• The company's stock price may be subject to delisting from the Nasdaq Capital Market if it does not regain compliance with the minimum bid price requirement.
• The company's investments in the solar energy sector may not yield a return.

Future Outlook

The company expects to continue to generate losses and negative cash flows from operations for the foreseeable future and is seeking additional financing through the sale of equity securities or strategic partnerships. Management believes that existing cash will be sufficient to fund operations until the end of the third quarter of 2025.

Management Comments

• Management is of the opinion that its existing cash will be sufficient to fund operations until the end of the third quarter of 2025.
• Management endeavors to secure sufficient financing through the sale of additional equity securities or capital inflows from strategic partnerships.

Industry Context

The company operates in the agri-food tech sector, focusing on eco-friendly solutions for food safety and shelf life. The company is also involved in the global warming solutions sector through its subsidiary NTWO OFF Ltd. The company's performance is affected by broader industry trends, including the demand for sustainable food solutions and the need to reduce greenhouse gas emissions. The company faces competition from other companies developing similar solutions.

Comparison to Industry Standards

• The company's revenue decline of 56% year-over-year is significant and indicates a potential struggle to gain market traction compared to industry peers.
• The substantial reduction in R&D spending, while improving short-term financials, may impact the company's long-term competitiveness and innovation pipeline compared to other companies in the agri-food tech sector.
• The company's reliance on external financing and the going concern uncertainty are concerning and may be viewed negatively compared to more established companies in the industry.
• The company's investment in solar energy is a strategic move that could provide diversification and potential future revenue streams, but it also introduces additional risk compared to companies solely focused on food technology.
• The company's Nasdaq non-compliance is a significant issue that could lead to delisting, which would be a major setback compared to companies that maintain listing requirements.

Management Changes

Corporate Governance

Related Party Transactions

• The company's chairman of the board of directors is also a shareholder and director of AI Conversation Systems Ltd., that may merge with Solterra.
• The company has related party transactions with directors and officers, including compensation and share-based payments.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares.
• Employees may be affected by the ongoing conflict in Israel and potential disruptions to operations.
• Customers may experience delays in product delivery due to the conflict in Israel.
• Suppliers may be affected by the conflict in Israel and potential disruptions to the supply chain.
• Creditors may be concerned about the company's ability to repay its debts due to its financial struggles.

Next Steps

• The company needs to regain compliance with the Nasdaq minimum bid price requirement by January 6, 2025.
• The company needs to secure additional financing to support its operations.
• The company needs to finalize the acquisition of MitoCareX Bio Ltd.
• The company needs to continue to develop and commercialize its products.
• The company needs to monitor the ongoing conflict in Israel and its impact on operations.

Key Dates

Keywords

N2OFF, agri-food tech, food safety, shelf life, pathogen prevention, nitrous oxide emissions, solar energy, Plantify Foods, MitoCareX Bio, Nasdaq, financial results, Israel, reverse stock split, standby equity purchase agreement